IBDEI05I ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6823,0)
 ;;=N41.9^^26^404^39
 ;;^UTILITY(U,$J,358.3,6823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6823,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,6823,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,6823,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,6824,0)
 ;;=N70.91^^26^404^79
 ;;^UTILITY(U,$J,358.3,6824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6824,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,6824,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,6824,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,6825,0)
 ;;=N70.93^^26^404^78
 ;;^UTILITY(U,$J,358.3,6825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6825,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,6825,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,6825,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,6826,0)
 ;;=N70.92^^26^404^56
 ;;^UTILITY(U,$J,358.3,6826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6826,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,6826,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,6826,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,6827,0)
 ;;=N73.9^^26^404^38
 ;;^UTILITY(U,$J,358.3,6827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6827,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,6827,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,6827,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,6828,0)
 ;;=A56.11^^26^404^37
 ;;^UTILITY(U,$J,358.3,6828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6828,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,6828,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,6828,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,6829,0)
 ;;=N73.5^^26^404^65
 ;;^UTILITY(U,$J,358.3,6829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6829,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,6829,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,6829,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,6830,0)
 ;;=N72.^^26^404^36
 ;;^UTILITY(U,$J,358.3,6830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6830,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,6830,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,6830,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,6831,0)
 ;;=N76.3^^26^404^96
 ;;^UTILITY(U,$J,358.3,6831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6831,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,6831,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,6831,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,6832,0)
 ;;=N76.1^^26^404^92
 ;;^UTILITY(U,$J,358.3,6832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6832,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,6832,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,6832,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,6833,0)
 ;;=N76.2^^26^404^95
 ;;^UTILITY(U,$J,358.3,6833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6833,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,6833,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,6833,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,6834,0)
 ;;=N76.0^^26^404^91
 ;;^UTILITY(U,$J,358.3,6834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6834,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,6834,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,6834,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,6835,0)
 ;;=M00.20^^26^404^4
 ;;^UTILITY(U,$J,358.3,6835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6835,1,3,0)
 ;;=3^Arthritis Streptococcal,Unspec Joint
 ;;^UTILITY(U,$J,358.3,6835,1,4,0)
 ;;=4^M00.20
 ;;^UTILITY(U,$J,358.3,6835,2)
 ;;=^5009645
 ;;^UTILITY(U,$J,358.3,6836,0)
 ;;=M00.80^^26^404^5
 ;;^UTILITY(U,$J,358.3,6836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6836,1,3,0)
 ;;=3^Arthritis d/t Bacteria,Unspec Joint
 ;;^UTILITY(U,$J,358.3,6836,1,4,0)
 ;;=4^M00.80
 ;;^UTILITY(U,$J,358.3,6836,2)
 ;;=^5009669
 ;;^UTILITY(U,$J,358.3,6837,0)
 ;;=M00.9^^26^404^76
 ;;^UTILITY(U,$J,358.3,6837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6837,1,3,0)
 ;;=3^Pyogenic Arthritis,Unspec
 ;;^UTILITY(U,$J,358.3,6837,1,4,0)
 ;;=4^M00.9
 ;;^UTILITY(U,$J,358.3,6837,2)
 ;;=^5009693
 ;;^UTILITY(U,$J,358.3,6838,0)
 ;;=M00.00^^26^404^82
 ;;^UTILITY(U,$J,358.3,6838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6838,1,3,0)
 ;;=3^Staphylococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,6838,1,4,0)
 ;;=4^M00.00
 ;;^UTILITY(U,$J,358.3,6838,2)
 ;;=^5009597
 ;;^UTILITY(U,$J,358.3,6839,0)
 ;;=M00.10^^26^404^69
 ;;^UTILITY(U,$J,358.3,6839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6839,1,3,0)
 ;;=3^Pneumococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,6839,1,4,0)
 ;;=4^M00.10
 ;;^UTILITY(U,$J,358.3,6839,2)
 ;;=^5009621
 ;;^UTILITY(U,$J,358.3,6840,0)
 ;;=M86.20^^26^404^63
 ;;^UTILITY(U,$J,358.3,6840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6840,1,3,0)
 ;;=3^Osteomyelitis,Subacute,Unspec Site
 ;;^UTILITY(U,$J,358.3,6840,1,4,0)
 ;;=4^M86.20
 ;;^UTILITY(U,$J,358.3,6840,2)
 ;;=^5014535
 ;;^UTILITY(U,$J,358.3,6841,0)
 ;;=M86.10^^26^404^59
 ;;^UTILITY(U,$J,358.3,6841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6841,1,3,0)
 ;;=3^Osteomyelitis,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,6841,1,4,0)
 ;;=4^M86.10
 ;;^UTILITY(U,$J,358.3,6841,2)
 ;;=^5014521
 ;;^UTILITY(U,$J,358.3,6842,0)
 ;;=M86.00^^26^404^58
 ;;^UTILITY(U,$J,358.3,6842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6842,1,3,0)
 ;;=3^Osteomyelitis,Acute Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,6842,1,4,0)
 ;;=4^M86.00
 ;;^UTILITY(U,$J,358.3,6842,2)
 ;;=^5014497
 ;;^UTILITY(U,$J,358.3,6843,0)
 ;;=M86.50^^26^404^60
 ;;^UTILITY(U,$J,358.3,6843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6843,1,3,0)
 ;;=3^Osteomyelitis,Chronic Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,6843,1,4,0)
 ;;=4^M86.50
 ;;^UTILITY(U,$J,358.3,6843,2)
 ;;=^5014607
 ;;^UTILITY(U,$J,358.3,6844,0)
 ;;=M86.30^^26^404^61
 ;;^UTILITY(U,$J,358.3,6844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6844,1,3,0)
 ;;=3^Osteomyelitis,Chronic Multifocal,Unspec Site
 ;;^UTILITY(U,$J,358.3,6844,1,4,0)
 ;;=4^M86.30
 ;;^UTILITY(U,$J,358.3,6844,2)
 ;;=^5014559
 ;;^UTILITY(U,$J,358.3,6845,0)
 ;;=M86.8X9^^26^404^64
 ;;^UTILITY(U,$J,358.3,6845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6845,1,3,0)
 ;;=3^Osteomyelitis,Unspec Sites
 ;;^UTILITY(U,$J,358.3,6845,1,4,0)
 ;;=4^M86.8X9
 ;;^UTILITY(U,$J,358.3,6845,2)
 ;;=^5014655
 ;;^UTILITY(U,$J,358.3,6846,0)
 ;;=M86.60^^26^404^62
 ;;^UTILITY(U,$J,358.3,6846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6846,1,3,0)
 ;;=3^Osteomyelitis,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,6846,1,4,0)
 ;;=4^M86.60
 ;;^UTILITY(U,$J,358.3,6846,2)
 ;;=^5014630
 ;;^UTILITY(U,$J,358.3,6847,0)
 ;;=M86.40^^26^404^57
 ;;^UTILITY(U,$J,358.3,6847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6847,1,3,0)
 ;;=3^Osteomyelitis w/ Draining Sinus,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,6847,1,4,0)
 ;;=4^M86.40
 ;;^UTILITY(U,$J,358.3,6847,2)
 ;;=^5014583
 ;;^UTILITY(U,$J,358.3,6848,0)
 ;;=R50.2^^26^404^24
 ;;^UTILITY(U,$J,358.3,6848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6848,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,6848,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,6848,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,6849,0)
 ;;=R50.9^^26^404^28
 ;;^UTILITY(U,$J,358.3,6849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6849,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,6849,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,6849,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,6850,0)
 ;;=R76.11^^26^404^1
 ;;^UTILITY(U,$J,358.3,6850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6850,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,6850,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,6850,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,6851,0)
 ;;=Z21.^^26^404^31
 ;;^UTILITY(U,$J,358.3,6851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6851,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,6851,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,6851,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,6852,0)
 ;;=B37.0^^26^404^17
 ;;^UTILITY(U,$J,358.3,6852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6852,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,6852,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,6852,2)
 ;;=^5000612
 ;;^UTILITY(U,$J,358.3,6853,0)
 ;;=B97.10^^26^404^23
 ;;^UTILITY(U,$J,358.3,6853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6853,1,3,0)
 ;;=3^Enterovirus,Unspec,as Cause of Disease
 ;;^UTILITY(U,$J,358.3,6853,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,6853,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,6854,0)
 ;;=R50.82^^26^404^25
 ;;^UTILITY(U,$J,358.3,6854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6854,1,3,0)
 ;;=3^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,6854,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,6854,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,6855,0)
 ;;=R50.83^^26^404^27
 ;;^UTILITY(U,$J,358.3,6855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6855,1,3,0)
 ;;=3^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,6855,1,4,0)
 ;;=4^R50.83
 ;;^UTILITY(U,$J,358.3,6855,2)
 ;;=^5019510
 ;;^UTILITY(U,$J,358.3,6856,0)
 ;;=R50.84^^26^404^26
 ;;^UTILITY(U,$J,358.3,6856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6856,1,3,0)
 ;;=3^Fever,Posttransfusion
 ;;^UTILITY(U,$J,358.3,6856,1,4,0)
 ;;=4^R50.84
 ;;^UTILITY(U,$J,358.3,6856,2)
 ;;=^5019511
 ;;^UTILITY(U,$J,358.3,6857,0)
 ;;=B02.23^^26^404^74
 ;;^UTILITY(U,$J,358.3,6857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6857,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,6857,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,6857,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,6858,0)
 ;;=B02.22^^26^404^75
 ;;^UTILITY(U,$J,358.3,6858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6858,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,6858,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,6858,2)
 ;;=^266546
 ;;^UTILITY(U,$J,358.3,6859,0)
 ;;=J03.91^^26^404^84
 ;;^UTILITY(U,$J,358.3,6859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6859,1,3,0)
 ;;=3^Tonsillitis,Acute Recurrent,Unspec
